 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)品 > 分析標(biāo)準(zhǔn)品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：G797660 |
| 產(chǎn)品名稱：GSK503 |
| 產(chǎn)品CAS：1346572-63-1 |
| 規(guī)格含量：50mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
G797660 |
| 名稱: |
GSK503 |
| 別名: |
N-[(4,6-Dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-(1-methylethyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide; N-?[(1,?2-?Dihydro-?4,?6-?dimethyl-?2-?oxo-?3-?pyridinyl)?methyl]?-?3-?methyl-?1-?(1-?methylethyl)?-?6-?[6-?(4-?methyl-?1-?piperazinyl)?-?3-?pyridinyl]?-1H-?indole-?4-?carboxamide |
| CAS號(hào): |
1346572-63-1 |
| 分子式: |
C??H??N?O? |
| 分子量: |
526.67 |
| 種類: |
Research Tools; |
| 應(yīng)用: |
GSK503 is an EZH2 inhibitor for treating cancer. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
